Mission Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $394K | Sell |
751
-35
| -4% | -$18.4K | 0.01% | 509 |
|
|
2025
Q1 | $498K | Buy |
786
+254
| +48% | +$161K | 0.01% | 424 |
|
|
2024
Q4 | $379K | Sell |
532
-1,804
| -77% | -$1.28M | 0.01% | 479 |
|
|
2024
Q3 | $2.46M | Buy |
2,336
+409
| +21% | +$430K | 0.06% | 156 |
|
|
2024
Q2 | $2.03M | Buy |
1,927
+77
| +4% | +$80.9K | 0.05% | 162 |
|
|
2024
Q1 | $1.78M | Buy |
1,850
+1,379
| +293% | +$1.33M | 0.05% | 188 |
|
|
2023
Q4 | $414K | Buy |
471
+19
| +4% | +$16.7K | 0.01% | 399 |
|
|
2023
Q3 | $372K | Hold |
452
| – | – | 0.01% | 389 |
|
|
2023
Q2 | $325K | Buy |
452
+17
| +4% | +$12.2K | 0.01% | 423 |
|
|
2023
Q1 | $358K | Buy |
435
+15
| +4% | +$12.3K | 0.02% | 391 |
|
|
2022
Q4 | $303K | Buy |
+420
| New | +$303K | 0.01% | 405 |
|